ClinicalTrials.gg
Status unknownNCT04295590Updated Mar 4, 2020

Impact of Augmenting Exercise Intensity vs. Frequency

An interventional study of Frequency comparison and Intensity comparison in Exercise Training, sponsored by Brendon Gurd, PhD. Status unknown at 1 site in Canada. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-04.

Sponsored by Brendon Gurd, PhD · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Sep 2019, registered Mar 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The purpose of this study is to compare the impact of augmenting exercise intensity and augmenting exercise frequency on peak work rate. Participants will complete exercise tests and provide 8 skeletal muscle samples following a within-subjects randomized crossover design utilizing single-leg cycling. Both training periods will be 4 weeks long and skeletal muscle biopsies will be collected from both legs before and after each training period. All exercise sessions will be supervised, take place in the investigator's laboratory, and occur on stationary bikes.

02

Conditions studied

  • Exercise Training
03

In context

Lead sponsor

Brendon Gurd, PhD is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Recreational active (\<3 hours per week of aerobic exercise)
  • Willing to provide skeletal muscle biopsies

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular or metabolic disease
  • Athletes or individuals exceeding 3 hours per week of aerobic exercise
  • Smokers
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Frequency then Intensity

    Training period 1: Frequency comparison Training period 2: Intensity comparison

    Behavioral: Frequency comparison · Behavioral: Intensity comparison

  • Experimental
    Intensity then Frequency

    Training period 1: Intensity comparison Training period 2: Frequency comparison

    Behavioral: Frequency comparison · Behavioral: Intensity comparison

Interventions

  • BehavioralFrequency comparison

    One leg assigned to low-frequency low-intensity (3 days per week of 11 x 1 min @ 73% peak work rate interspersed with 1-minute periods of active recovery). The other leg assigned to high-frequency low-intensity (5 days per week of 11 x 1 min @ 73% peak work rate interspersed with 1-minute periods of active recovery).

  • BehavioralIntensity comparison

    One leg assigned to low-frequency low-intensity (3 days per week of 11 x 1 min @ 73% peak work rate interspersed with 1-minute periods of active recovery). The other leg assigned to low-frequency high-intensity (3 days per week of 8 x 1 min @ 100% peak work rate interspersed with 1-minute periods of active recovery).

06

What researchers measure

Primary outcomes

  1. Peak work rate

    Change in Highest work rate achieved (30s period) during incremental exercise tests

    Time frame: Before exercise training on two days (~7 and 6 days before first training session; ~24 hours apart), and after exercise on two days (~48-96 hours after the last training session; ~24 hours apart)

Secondary outcomes

  1. Peak oxygen uptake

    Change in Highest oxygen uptake achieved (30s period) during incremental exercise tests

    Time frame: Before exercise training on two days (~7 and 6 days before first training session; ~24 hours apart), and after exercise on two days (~48-96 hours after the last training session; ~24 hours apart)

  2. Maximal citrate synthase activity

    Change in maximal citrate synthase activity

    Time frame: Before exercise training (~7 days before first training session), and after exercise training (~48-72 hours after the last training session)

07

Study locations

1 site
  • Queen's Muscle Physiology Lab in the School of Kinesiology and Health Studies at Queen's University
    Kingston, Ontario K7L 3N6, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2019 (actual). Primary completion is estimated for Apr 2020, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2020
First posted
Mar 4, 2020
StartActual
Sep 30, 2019
Primary completionEst.
Apr 10, 2020
CompletionEst.
Apr 10, 2020
Last update
Mar 4, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04295590
Lead sponsor
Brendon Gurd, PhD
Collaborators
Queen's University
Responsible party
Brendon Gurd, PhD (Professor, School of Kinesiology & Health Studies, Queen's University, Queen's University) — Sponsor-investigator
First posted
Mar 4, 2020
Start date
Sep 30, 2019
Primary completion
Apr 10, 2020 (estimated)
Completion
Apr 10, 2020 (estimated)
Last update
Mar 4, 2020

Study contacts

Brendon J Gurd, PhD
principal investigator · Queen's University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion